Canton Strategic Holdings, Inc. (CNTN)
2.14
+0.06
(+2.88%)
USD |
NASDAQ |
Sep 03, 12:54
Canton Strategic Holdings Total Assets (Quarterly) : 564.57M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 564.57M |
| March 31, 2026 | 584.65M |
| December 31, 2025 | 519.15M |
| September 30, 2025 | 7.699M |
| June 30, 2025 | 2.530M |
| March 31, 2025 | 1.661M |
| December 31, 2024 | 3.722M |
| September 30, 2024 | 5.251M |
| June 30, 2024 | 8.257M |
| March 31, 2024 | 8.887M |
| December 31, 2023 | 10.95M |
| Date | Value |
|---|---|
| September 30, 2023 | 3.167M |
| June 30, 2023 | 4.599M |
| March 31, 2023 | 4.722M |
| December 31, 2022 | 6.689M |
| September 30, 2022 | 7.833M |
| June 30, 2022 | 9.786M |
| March 31, 2022 | 11.36M |
| December 31, 2021 | 0.6217M |
| September 30, 2021 | 0.4149M |
| June 30, 2021 | 0.2831M |
| March 31, 2021 | 0.0828M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 14.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 109.67M |
| Shareholders Equity (Quarterly) | 454.90M |
| Current Ratio | 15.70 |
| Net Debt Paydown Yield | 0.05% |